These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 11434876)

  • 1. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR].
    Li J; Xu L; He K; Guo W; Zhu X; Zheng Y; Xia P
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modulation of multiple drug resistance by nomegestrol acetate and droloxifene in K562/A02].
    Li J; Xu L; He K
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):288-91. PubMed ID: 11721384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
    Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine].
    Cheng YH; Qi J; Xiong DS; Liu JW; Qi SL; Pan B; Yang CZ; Zhu HF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):164-8. PubMed ID: 16733896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
    Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
    Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
    Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
    Wang F; Jiang X; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
    Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
    Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
    J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
    Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
    Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
    Li T; Kong AN; Ma Z; Liu H; Liu P; Xiao Y; Jiang X; Wang L
    Oncotarget; 2016 Apr; 7(15):20236-48. PubMed ID: 26934120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
    Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.